Simplifying Global Compliance
FDA Holds on Imported Products Can Be Subjective, Experts Say
Washington Drug Letter
Decisions on banning imported products can be based on a variety of factors, so companies must be prepared to challenge an import hold with the FDA, industry experts said at an FDAnews audioconference.
To View This Article:
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing